Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1239 press releases before 2023
-
Health Canada approves BRILINTA (ticagrelor tablets)
-
AstraZeneca signs agreement in Japan with Daiichi Sankyo to co-promote denosumab for cancer
-
Health economics substudy of PLATO shows BRILIQUE to be a cost effective treatment versus generic Clopidogrel
-
AstraZeneca PLC First Quarter Results 2011
-
FDA approves orphan drug vandetanib
-
UK and US governments reach agreement over AstraZeneca tax matters
-
AstraZeneca initiates phase III clinical programme evaluating NKTR-118 for treatment of opioid-induced constipation
-
FDA accepts new drug application for investigational compound Dapagliflozin for the treatment of type 2 diabetes
-
AstraZeneca to discontinue production of PULMICORT® pMDI, other respiratory medicines not affected
-
Onglyza becomes the first DPP4 inhibitor available for use in Europe in Type 2 Diabetes patients with moderate or severe renal impairment
Latest articles and press releases
All of our latest press releases and articles are available to explore
